000 01638 a2200469 4500
005 20250512115148.0
264 0 _c19741219
008 197412s 0 0 eng d
022 _a0098-7484
024 7 _a10.1001/jama.230.2.270
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDykes, M H
245 0 0 _aEvaluation of three anorexiants. Clortermine hydrochloride (voranil), fenfluramine hydrochloride (pondimin), and mazindol (sanorex).
_h[electronic resource]
260 _bJAMA
_cOct 1974
300 _a270-2 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAge Factors
650 0 4 _aAppetite Depressants
_xtherapeutic use
650 0 4 _aClinical Trials as Topic
650 0 4 _aDepression
_xchemically induced
650 0 4 _aDiet, Reducing
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aFenfluramine
_xadministration & dosage
650 0 4 _aHeadache
_xchemically induced
650 0 4 _aHumans
650 0 4 _aImidazoles
_xadministration & dosage
650 0 4 _aIndoles
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aNausea
_xchemically induced
650 0 4 _aObesity
_xdrug therapy
650 0 4 _aPhenethylamines
_xadministration & dosage
650 0 4 _aPlacebos
650 0 4 _aSubstance Withdrawal Syndrome
650 0 4 _aSubstance-Related Disorders
650 0 4 _aTime Factors
650 0 4 _aVomiting
_xchemically induced
773 0 _tJAMA
_gvol. 230
_gno. 2
_gp. 270-2
856 4 0 _uhttps://doi.org/10.1001/jama.230.2.270
_zAvailable from publisher's website
999 _c4610451
_d4610451